COVID-19: DCGI nod to Gennova's indigenous mRNA vaccine for emergency use in 18 years and above; SII's Covovax for 7-11 years Ruchika Sharma29 Jun 2022 4:30 AM GMTGennova developed the mRNA vaccine with the support of the Department of Biotechnology (DBT) under the Ministry of Science and Technology and its PSU,...
Gennova Biopharma COVID vaccine currently under final clinical trial stages: Government Ruchika Sharma13 Feb 2022 2:30 AM GMTThe official noted that the vaccine can be stored in normal cold chain conditions and transported, which is a "big thing".
Gennova gets DCGI nod for Phase 2, 3 trials of its mRNA COVID vaccine Ruchika Sharma25 Aug 2021 6:58 AM GMTNew Delhi: India's first mRNA-based Covid-19 vaccine candidate HGCO19 by Gennova Biopharmaceuticals Ltd has been granted approval for phase 2/3...
Gennova begins enrolment for Phase human clinical trials of HGCO19 vaccine candidate Ruchika Sharma13 April 2021 12:08 PM GMTNew Delhi: Gennova has initiated the enrolment of volunteers for Phase 1/2 clinical trials for its mRNA vaccine candidate HGCO19, the Department of...
Gennova Biopharma wins DCGI conditional nod for human clinical trial of Covid-19 vaccine Ruchika Sharma11 Dec 2020 1:19 PM GMTThe recommendations of the Subject Expert Committee (SEC) on Covid19, which deliberated upon the proposal submitted by the firm for grant of...
Govt panel meets COVID vaccine makers including Serum Institute, Zydus Cadila, others Ruchika Sharma18 Aug 2020 7:30 AM GMTNew Delhi: The national expert group on vaccine administration for Covid-19 met representatives of leading domestic manufactures, including Serum...
